Profile | GDS4284 / 217741_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 3675.79 | 91 |
GSM687648 | Patient 402 control | 3352.04 | 90 |
GSM687653 | Patient 403 control | 2395.98 | 86 |
GSM687658 | Patient 404 control | 2181.55 | 85 |
GSM687663 | Patient 411 control | 2661.88 | 88 |
GSM687668 | Patient 422 control | 3165.9 | 89 |
GSM687673 | Patient 424 control | 5454.36 | 94 |
GSM687678 | Patient 425 control | 3032.01 | 89 |
GSM687683 | Patient 427 control | 4373.24 | 92 |
GSM687688 | Patient 428 control | 1684.15 | 81 |
GSM687695 | Patient 441 control | 16306.4 | 98 |
GSM687699 | Patient 443 control | 1382.83 | 79 |
GSM687704 | Patient 444 control | 1894.95 | 83 |
GSM687707 | Patient 448 control | 3259.98 | 90 |
GSM687712 | Patient 449 control | 2968.02 | 89 |
GSM687719 | Patient 450 control | 3126.48 | 89 |
GSM687724 | Patient 451 control | 3918.74 | 91 |
GSM687728 | Patient 452 control | 4724.43 | 93 |
GSM687646 | Patient 401 treated 24h | 2428.96 | 86 |
GSM687649 | Patient 402 treated 24h | 4018.56 | 91 |
GSM687665 | Patient 411 treated 24h | 2886.66 | 88 |
GSM687651 | Patient 402 treated 4 weeks | 3030.27 | 89 |
GSM687667 | Patient 411 treated 4 weeks | 3028.94 | 89 |
GSM687670 | Patient 422 treated 24h | 3038.06 | 89 |
GSM687671 | Patient 422 treated 4 weeks | 3914.09 | 91 |
GSM687654 | Patient 403 treated 24h | 1923.3 | 83 |
GSM687675 | Patient 424 treated 24h | 6597.86 | 95 |
GSM687685 | Patient 427 treated 24h | 3065.21 | 89 |
GSM687656 | Patient 403 treated 4 weeks | 3231.09 | 89 |
GSM687677 | Patient 424 treated 4 weeks | 2445.48 | 86 |
GSM687687 | Patient 427 treated 4 weeks | 3104.44 | 89 |
GSM687692 | Patient 428 treated 4h | 1916.36 | 83 |
GSM687716 | Patient 449 treated 4h | 2313.74 | 86 |
GSM687722 | Patient 450 treated 4h | 3696.14 | 91 |
GSM687680 | Patient 425 treated 24h | 3306 | 90 |
GSM687690 | Patient 428 treated 24h | 2359.1 | 86 |
GSM687700 | Patient 443 treated 24h | 4861.79 | 94 |
GSM687705 | Patient 444 treated 24h | 2507.63 | 87 |
GSM687714 | Patient 449 treated 24h | 3545.19 | 90 |
GSM687721 | Patient 450 treated 24h | 7591.57 | 96 |
GSM687682 | Patient 425 treated 4 weeks | 1811.52 | 83 |
GSM687694 | Patient 428 treated 4 weeks | 1705.46 | 81 |
GSM687702 | Patient 443 treated 4 weeks | 2539.82 | 87 |
GSM687718 | Patient 449 treated 4 weeks | 2401.97 | 86 |
GSM687723 | Patient 450 treated 4 weeks | 2321.32 | 86 |
GSM687661 | Patient 404 treated 4h | 2929.01 | 88 |
GSM687710 | Patient 448 treated 4h | 3945.17 | 91 |
GSM687726 | Patient 451 treated 4h | 3639.4 | 91 |
GSM687730 | Patient 452 treated 4h | 5922.41 | 95 |
GSM687660 | Patient 404 treated 24h | 6005.5 | 94 |
GSM687697 | Patient 441 treated 24h | 8456.26 | 96 |
GSM687709 | Patient 448 treated 24h | 3560.71 | 90 |
GSM687725 | Patient 451 treated 24h | 5382.49 | 94 |
GSM687729 | Patient 452 treated 24h | 10351.8 | 97 |
GSM687727 | Patient 451 treated 4 weeks | 3818.88 | 91 |
GSM687731 | Patient 452 treated 4 weeks | 5429.69 | 94 |